Literature DB >> 12883830

Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.

Osamu Yokota1, Seishi Terada, Hideki Ishizu, Hiroshi Ujike, Takeshi Ishihara, Masuyuki Namba, Yasuaki Hayashi, Tetsuya Nishinaka, Reiko Namba, Hanae Nakashima, Kenji Uéda, Frédéric Checler, Shigetoshi Kuroda.   

Abstract

We describe three cases of early- (cases 1-3, 28-39 years) and one of late-onset (case 4, 76 years) Alzheimer's disease (AD) with 'cotton wool' plaques (CWPs) but without a family history indicating autosomal dominant inheritance. The early-onset cases, but not the late-onset case, showed remarkable aggression, disinhibition, and impulsiveness. Spastic paraparesis was observed in only one early-onset case. Hematoxylin-eosin-stained sections showed numerous CWPs, especially in the temporal cortex, in all cases. Bielschowsky-stained sections showed neurofibrillary tangles and minor neuritic changes surrounding the CWPs in three cases, but not in case 2. Gallyas-Braak-stained sections showed weak argyrophilia in homogeneous material of the CWPs in cases 2 and 4. Quantitative analysis demonstrated that Abeta42 was deposited more predominantly than Abeta40 in three cases. However, in case 2, approximately twice as much Abeta40 as Abeta42 was deposited. Tau immunostaining demonstrated neuritic changes in three cases, but not in case 2. alpha-Synuclein-positive Lewy bodies (LBs) and astrocytic lesions containing non-Abeta component of AD amyloid (NAC), a central fragment of alpha-synuclein, were found in case 3. In conclusion, (1) a frontal lobe syndrome-like personality change may be one of the characteristic clinical features of early-onset CWP-AD, (2) the deposition pattern of Abeta40 and Abeta42 in CWP-AD is more variable than that of presenilin-1-linked cases, (3) Abeta deposition can result in development of dementia without tau pathology, and (4) CWP-AD with LBs and several other neurodegenerative disorders with LBs share a common process involving alpha-synuclein and NAC deposition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883830     DOI: 10.1007/s00401-003-0737-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

Review 1.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

Review 2.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

3.  The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2011-06-15       Impact factor: 3.688

4.  Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.

Authors:  Steffan K Soosman; Nelly Joseph-Mathurin; Meredith N Braskie; Yvette M Bordelon; David Wharton; Maria Casado; Giovanni Coppola; Holly McCallum; Marc Nuwer; Pedro Coutin-Churchman; Liana G Apostolova; Tammie Benzinger; John M Ringman
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

5.  Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn.

Authors:  Stanislav Sutovsky; Tomas Smolek; Peter Turcani; Robert Petrovic; Petra Brandoburova; Santosh Jadhav; Petr Novak; Johannes Attems; Norbert Zilka
Journal:  J Neural Transm (Vienna)       Date:  2018-02-05       Impact factor: 3.575

6.  Young adult-onset, very slowly progressive cognitive decline with spastic paraparesis in Alzheimer's disease with cotton wool plaques due to a novel presenilin1 G417S mutation.

Authors:  Tomoko Miki; Osamu Yokota; Takashi Haraguchi; Takeshi Ikeuchi; Bin Zhu; Shintaro Takenoshita; Seishi Terada; Norihito Yamada
Journal:  Acta Neuropathol Commun       Date:  2019-02-12       Impact factor: 7.801

7.  Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.

Authors:  Arno de Wilde; Juhan Reimand; Charlotte E Teunissen; Marissa Zwan; Albert D Windhorst; Ronald Boellaard; Wiesje M van der Flier; Philip Scheltens; Bart N M van Berckel; Femke Bouwman; Rik Ossenkoppele
Journal:  Alzheimers Res Ther       Date:  2019-09-12       Impact factor: 6.982

8.  Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study.

Authors:  M Byford; C Brayne; I McKeith; M Chatfield; Pg Ince; Fe Matthews
Journal:  BMC Geriatr       Date:  2009-06-15       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.